Table 1.
Characteristics of 161 study patients.
| Parameter | No. of Patients (%) |
|---|---|
| Age, years | |
| ≤57 | 85 (52.8%) |
| >57 | 76 (47.2%) |
| Sex | |
| Female | 71 (44.1%) |
| Male | 90 (55.9%) |
| Smoking History | |
| No | 116 (72%) |
| Yes | 45 (28%) |
| Anatomical location | |
| Peripheral | 105 (65.2%) |
| Central | 56 (34.8%) |
| EGFR | |
| Sensitive mutations | 47 (29.2%) |
| Negative | 79 (49.1%) |
| Resistant mutations | 4 (2.5%) |
| Not available | 31 (19.2%) |
| Bone metastasis | |
| No | 100 (62.1%) |
| Yes | 61 (37.9%) |
| Brain metastasis | |
| No | 110 (68.3%) |
| Yes | 51 (31.7%) |
| Liver metastasis | |
| No | 135 (83.9%) |
| Yes | 26 (16.1%) |
| Baseline NLR | |
| ≤3.87 | 114 (70.8%) |
| >3.87 | 47 (29.2%) |
| Baseline PLR | |
| ≤156 | 56 (34.8%) |
| >156 | 105 (65.2%) |
| Baseline SII | |
| ≤824 | 98 (60.9%) |
| >824 | 63 (39.1%) |
| Baseline LMR | |
| ≤2.37 | 55 (34.2%) |
| >2.37 | 106 (65.8%) |